Curida, Small Molecules and Biologics CDMO, Secures Private Equity Investment from Signet Healthcare Partners
Curida Holding AS (“Curida”) has announced a significant growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare private equity firm.
- Curida Holding AS (“Curida”) has announced a significant growth investment from Signet Healthcare Partners (“Signet”), a New York-based healthcare private equity firm.
- This strategic partnership will enable Curida to accelerate its expansion plans, including enhancing facility capabilities and growing its industry position.
- Curida’s customer base ranges from small to medium-sized pharmaceutical, medical devices, and biotech companies, delivering solutions in drug development and GMP manufacturing globally.
- In conjunction with Signet’s investment, Signet is joining the Board of Directors, and Ole J. Dahlberg has been appointed as Chairman of the Board.